IDEXX Laboratories, Inc. (IDXX) 의 후행 P/E는 44.1, 선행 P/E 40.2. 후행 이익수익률은 2.27%, 선행 이익수익률 2.49%. PEG 1.95. 그레이엄 넘버는 $77.23.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 71/100 5/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 47.4 | 2.45 | -97.12 | 5.93 | - |
| 2017 | 52.2 | 2.43 | -253.67 | 6.97 | - |
| 2018 | 42.9 | 0.96 | -1,698.56 | 7.30 | - |
| 2019 | 52.6 | 3.62 | 126.71 | 9.34 | - |
| 2020 | 73.3 | 1.97 | 67.49 | 15.76 | - |
| 2021 | 75.3 | 2.68 | 81.31 | 17.45 | - |
| 2022 | 50.2 | -7.08 | 56.04 | 10.13 | - |
| 2023 | 54.6 | 2.16 | 31.06 | 12.59 | - |
| 2024 | 38.4 | 6.51 | 21.37 | 8.75 | - |
| 2025 | 51.1 | 2.30 | 33.75 | 12.59 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $2.44 | $1.78B | $222.05M | 12.5% |
| 2017 | $2.94 | $1.97B | $263.14M | 13.4% |
| 2018 | $4.26 | $2.21B | $377.03M | 17% |
| 2019 | $4.89 | $2.41B | $427.72M | 17.8% |
| 2020 | $6.71 | $2.71B | $581.78M | 21.5% |
| 2021 | $8.60 | $3.22B | $744.85M | 23.2% |
| 2022 | $8.03 | $3.37B | $679.09M | 20.2% |
| 2023 | $10.06 | $3.66B | $845.04M | 23.1% |
| 2024 | $10.67 | $3.9B | $887.87M | 22.8% |
| 2025 | $13.08 | $4.3B | $1.06B | 24.6% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $14.56 | $14.40 – $14.74 | $4.68B | $4.67B – $4.71B | 11 |
| 2027 | $16.45 | $15.95 – $16.95 | $5.09B | $5.05B – $5.15B | 10 |
| 2028 | $18.75 | $17.56 – $19.89 | $5.58B | $5.58B – $5.58B | 8 |
| 2029 | $21.46 | $21.24 – $21.74 | $6.16B | $6.11B – $6.23B | 6 |
| 2030 | $26.21 | $25.95 – $26.56 | $7B | $6.94B – $7.07B | 6 |
